Relay Therapeutics, Inc. (RLAY)
13.66
+0.64
(+4.92%)
USD |
NASDAQ |
May 21, 16:00
13.64
-0.02
(-0.15%)
After-Hours: 19:59
Relay Therapeutics Research and Development Expense (TTM) : 258.14M for March 31, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Tyra Biosciences, Inc. | 110.89M |
| Spyre Therapeutics, Inc. | 190.44M |
| Revolution Medicines, Inc. | 1.117B |
| Tango Therapeutics, Inc. | 127.14M |
| Summit Therapeutics, Inc. | 619.03M |